Your browser doesn't support javascript.
loading
Typhoid fever.
Meiring, James E; Khanam, Farhana; Basnyat, Buddha; Charles, Richelle C; Crump, John A; Debellut, Frederic; Holt, Kathryn E; Kariuki, Samuel; Mugisha, Emmanuel; Neuzil, Kathleen M; Parry, Christopher M; Pitzer, Virginia E; Pollard, Andrew J; Qadri, Firdausi; Gordon, Melita A.
Affiliation
  • Meiring JE; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • Khanam F; Malawi-Liverpool-Wellcome Programme, Blantyre, Malawi.
  • Basnyat B; International Centre for Diarrhoel Disease Research, Dhaka, Bangladesh.
  • Charles RC; Oxford University Clinical Research Unit, Kathmandu, Nepal.
  • Crump JA; Massachusetts General Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Debellut F; Centre for International Health, University of Otago, Dunedin, New Zealand.
  • Holt KE; Center for Vaccine Innovation and Access, PATH, Geneva, Switzerland.
  • Kariuki S; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Mugisha E; Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Neuzil KM; Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Parry CM; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
  • Pitzer VE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Pollard AJ; Department of Clinical Sciences and Education, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK.
  • Qadri F; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Gordon MA; Department of Epidemiology of Microbial Diseases and Public Health Modelling Unit, Yale School of Public Health, Yale University, New Haven, CT, USA.
Nat Rev Dis Primers ; 9(1): 71, 2023 Dec 14.
Article in En | MEDLINE | ID: mdl-38097589
ABSTRACT
Typhoid fever is an invasive bacterial disease associated with bloodstream infection that causes a high burden of disease in Africa and Asia. Typhoid primarily affects individuals ranging from infants through to young adults. The causative organism, Salmonella enterica subsp. enterica serovar Typhi is transmitted via the faecal-oral route, crossing the intestinal epithelium and disseminating to systemic and intracellular sites, causing an undifferentiated febrile illness. Blood culture remains the practical reference standard for diagnosis of typhoid fever, where culture testing is available, but novel diagnostic modalities are an important priority under investigation. Since 2017, remarkable progress has been made in defining the global burden of both typhoid fever and antimicrobial resistance; in understanding disease pathogenesis and immunological protection through the use of controlled human infection; and in advancing effective vaccination programmes through strategic multipartner collaboration and targeted clinical trials in multiple high-incidence priority settings. This Primer thus offers a timely update of progress and perspective on future priorities for the global scientific community.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Typhoid Fever Limits: Adult / Humans / Infant Language: En Journal: Nat Rev Dis Primers Year: 2023 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Typhoid Fever Limits: Adult / Humans / Infant Language: En Journal: Nat Rev Dis Primers Year: 2023 Document type: Article Country of publication: United kingdom